Effect of Nigella sativa fixed and essential oils on antioxidant status, hepatic enzymes, and immunity in streptozotocin induced diabetes mellitus

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Sultan, Muhammad T ^a,b   Butt, Masood S ^c   Karim, Roselina ^a   Iqbal, Shahzad Z ^a   Ahmad, Shakeel ^d   Zia Ul Haq, Muhammad ^e   Aliberti, Luigi ^f   Ahmad, Atif N ^d   De Feo, Vincenzo ^f  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Department of Food Sciences Bahauddin Zakariya University Multan   (Malaysia)

^c UNIVERSITY OF AGRICULTURE   (Pakistan)

^d BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^e The Patent Office   (Pakistan)

^f UNIVERSITY OF SALERNO   (Italy)

Author keywords

Diabetes mellitus; Hyperglycemia; Nigella sativa; Oxidative stress; Traditional uses

Indexed keywords

ALPHA TOCOPHEROL; ESSENTIAL OIL; GAMMA TOCOPHEROL; GLUTATHIONE; LIVER ENZYME; NIGELLA SATIVA ESSENTIAL OIL; NIGELLA SATIVA FIXED OIL; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BLACK CUMIN; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DRUG EFFICACY; ENZYME ACTIVITY; IMMUNITY; IN VIVO STUDY; METABOLIC PARAMETERS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; HYPERGLYCEMIA; LIVER; NIGELLA SATIVA; NITRIC OXIDE; OILS, VOLATILE; OXIDATIVE STRESS; PEROXIDASE; PLANT OILS; RATS; RATS, SPRAGUE-DAWLEY; TOCOPHEROLS; XANTHINE OXIDASE;

EID: 84902302405     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-193     Document Type: Article

References (32)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Car 2004, 27:1047-1053.
2. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013, 93:137-188. 10.1152/physrev.00045.2011, 23303908.
3. Hung H-Y, Qian K, Morris-Natschke K, Hsu C-S, Lee K-H. Recent discovery of plant-derived anti-diabetic natural products. Nat Prod Rep 2012, 29:580-606. 10.1039/c2np00074a, 22491825.
4. Ozen AE, Pons A, Tur JA. Worldwide consumption of functional foods: a systematic review. Nutr Rev 2012, 70:472-481. 10.1111/j.1753-4887.2012.00492.x, 22835140.
5. Shabana A, El-Menyar A, Asim M, Al-Azzeh H, Al Thani H. Cardiovascular benefits of black cumin (Nigella sativa). Cardiovas Toxic 2013, 13:9-21.
6. Butt MS, Sultan MT. Selected functional foods for potential in diseases treatment and their regulatory issues. Int J Food Prop 2013, 16:397-415.
7. Guarrera PM, Savo V. Perceived health properties of wild and cultivated food plants in local and popular traditions of Italy: A review. J Ethnopharmacol 2013, 146:659-680. 10.1016/j.jep.2013.01.036, 23395624.
8. Sultan MT, Butt MS, Anjum FM. Safety assessment of black cumin fixed and essential oils in normal Sprague Dawley: serological and hematological indices. Food Chem Toxicol 2009, 47:2768-2775. 10.1016/j.fct.2009.08.011, 19699773.
9. Butt MS, Sultan MT. Nigella sativa reduces the risk of various maladies. Crit Rev Food Sci Nutr 2010, 50:654-665. 10.1080/10408390902768797, 20694927.
10. Hamdy NM, Taha RA. Effects of Nigella sativa oil and thymoquinone on oxidative stress and neuropathy in streptozotocin-induced diabetic rats. Pharmacology 2009, 84:127-134. 10.1159/000234466, 19684436.
11. Alenzi FQ, El-Bolkiny Y-S, Salem ML. Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide. Br J Biomed Sci 2010, 67:20-28.
12. Kanter M, Meral I, Yener Z, Ozbek H, Demir H. Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku J Exp Med 2003, 201:213-219. 10.1620/tjem.201.213, 14690013.
13. Sultan MT, Butt MS, Anjum FM, Jamil A, Akhtar S, Nasir M. Nutritional profile of indigenous cultivar of black cumin seeds and antioxidant potential of its fixed and essential oil. Pak J Bot 2009, 41:1321-1330.
14. Uchida K, Satoh T, Ogura Y, Yamaga N, Yamada K. Effect of partial ileal bypass on cholesterol and bile acid metabolism in rats. Yanago Acta Med 2001, 44:69-77.
15. Beutler E. A Manual of Biochemical Methods 1982, New York, USA: Grune and Stratton.
16. Xu Z, Godber JS. Purification and identification of components of gamma-oryzanol in rice bran oil. J Agric Food Chem 1999, 47:2724-2728. 10.1021/jf981175j, 10552553.
17. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988, 34:497-498.
18. Block PP, Karmer R, Paverka M. A simple assay for catalase determination. Cell Biol Monogr 1980, 7:44-47.
19. Tappel AL. Glutathione peroxidase and hydroperoxides. Method Enzymol 1978, 52:506-513.
20. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
21. Hillegas LM, Griswold DE, Brickson B, Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Meth 1990, 24:285-295.
22. Marcocci L, Suzuki YJ, Tsuchiya M, Packer L. Antioxidant activity of nitecapone and its analog OR-1246: effect of structural modification on antioxidant action. Method Enzymol 1994, 234:525-541.
23. Seven A, Guzel S, Seymen O, Civelek S, Bolayirli M, Yigit G. Nitric oxide synthase inhibition by L-NAME in streptozotocin induced diabetic rats:impacts on oxidative stress. Tohoku J Exp Med 2003, 99:205-210.
24. Huang H, Mai W, Liu D, Hao Y, Tao J, Dong Y. The oxidation ratio of LDL: a predictor for coronary artery disease. Dis Markers 2008, 24:341-349. 10.1155/2008/371314, 3850607, 18688083.
25. Abdel-Wahhab MA, Hassan AM, Amer HA, Naguib KM. Prevention of fumonisin-induced maternal and developmental toxicity in rats by certain plant extracts. J Appl Toxicol 2004, 24:469-474. 10.1002/jat.1000, 15551383.
26. Kaleem M, Kirmani D, Asif M, Ahmed Q, Bano B. Biochemical effects of Nigella sativa L seeds in diabetic rats. Ind J Exp Biol 2006, 44:745-748.
27. Sultan MT, Butt MS, Pasha I, Ahmad RS, Ahmad AN, Qayyum MMN. Supplementation of Nigella sativa fixed and essential oil mediates potassium bromate induced oxidative stress and multiple organ toxicity. Pak J Pharm Sci 2012, 25:175-181.
28. Ozkol H, Tuluce Y, Dilsiz N, Koyuncu I. Therapeutic potential of some plant extracts used in Turkish traditional medicine on streptozocin-induced type 1 diabetes mellitus in rats. J Membr Biol 2013, 246:47-55. 10.1007/s00232-012-9503-x, 23052826.
29. Lapshina EA, Sudnikovich EJ, Maksimchik JZ, Zabrodskaya A, Zavodnik LB, Kubyshin VL, Nocun M, Kazmierczak P, Dobaczewski M, Watala C, Zavodnik IB. Antioxidative enzyme and glutathione S-transferase activities in diabetic rats exposed to long-term ASA treatment. Life Sci 2006, 79:1804-1811. 10.1016/j.lfs.2006.06.008, 16815474.
30. Meral I, Yener Z, Kahraman T, Mert N. Effect of Nigella sativa on glucose concentration, lipid peroxidation, antioxidant defence system and liver damage in experimentally induced diabetic rabbits. J Vet Med 2001, 48:593-599.
31. Kanter M. Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res 2008, 33:87-96. 10.1007/s11064-007-9419-5, 17713854.
32. El-Mahmoudy A, Matsuyama H, Borgan MA, Shimizu Y, El-Sayed MG, Minamoto N, Takewaki T. Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. Int Immunopharmacol 2002, 2:1603-1611. 10.1016/S1567-5769(02)00139-X, 12433061.